See other companies on Welcome to the Jungle
AllStripes
Healthcare technology company
- 21-100 employees
- Healthcare
- B2C
- Personal health
- Biology
- Data Analysis
- Mid-Market, San Francisco, CA
Jump to section
Company mission
To unlock new treatments for people with rare disease.
14% employee growth in 12 months
Our take
About 1 in 10 people have a rare disease, and half are children. Patients, researchers, and doctors working or living with rare diseases receive little industry support. It can be hard to find health data, funding, or trial patients required to get drug development off the ground. This is where AllStripes (formerly known as RDMD) came in. Founded in 2017, AllStripes is a health-data repository for rare diseases.
The platform offers obvious clinical benefits, and seems a stable revenue model. Patients benefit from receiving a detailed, manageable medical file, and in exchange this data is “de-identified” by AllStripes and sold to drug developers for vital clinical research. AllStripes is not extending its platform to a social network like Patients Like Me, nor is it incentivising use with 23andMe-style perks. This laser focus on sharing data, whilst restrictive, is a smart long-term strategy, as it precludes complicated liability and privacy issues further down the line.
Co-Founder and CEO Nancy Yu worked on business at 23andMe, so is practiced in navigating regulatory restrictions on highly sensitive data. It's likely this cautious, ambitious, but hyper-specific proposition will continue to win AllStripes strong funding going forward.
In addition to North America, AllStripes has now hot stepped into the UK - the company's first major expansion and is planning to expand all over the globe.
Steph
Company Specialist at Welcome to the Jungle
Benefits
- Ginger.io, Headspace, Aaptiv & Physera
- Cell & internet reimbursement
- Team lunches & activities
- Home workstation setup budget
- 90% covered medical, dental & vision (75% for dependents)
- Responsible PTO + 14 paid holidays per year
- 12 weeks paid parental and family leave
- Health care FSA & dependent care FSA
- Life & disability insurance
- 401(k)
Company values
- We are dedicated to the rare disease community - We go above and beyond to be in service to our community
- We steer into hard problems - When faced with a challenge or problem, we get curious, learn and solve
- We embrace vulnerability - We create an open environment where team members are encouraged to express themselves
- We find joy in the work - We embrace joy and laughter as we work together, even through difficult challenges
Funding (last 2 of 3 rounds)
Aug 2021
$50m
SERIES B
Apr 2020
$14m
SERIES A
Total funding: $67.1m
This company has top investors
Leadership
Nancy Yu
(CEO)Former consultant at Living and Leader in Corporate development at 23andMe. Dual degree in Finance and Economics and Molecular Biology from University of Pennsylvania.